Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report

Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report

Abstract Background Interleukin-5 (IL-5) has recently been shown to play a crucial role in eosinophil-mediated diseases, implying that an IL-5 receptor alpha chain (IL-5Rα) antibody (benralizumab) can be effective against eosinophilic esophagitis (EoE). Here, we present a case in which benralizumab...

Full description

Bibliographic Details
Main Authors: Azusa Ishii, Tomofumi Shibata, Yohei Tsunoda, Takafumi Kayukawa, Masahiro Kobayashi, Masami Orinaka, Shoko Miyamatsu, Yoshio Ryuge, Shuichi Asano, Ichidai Tanaka
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Geriatrics
Subjects:
Eosinophilic esophagitis
Interleukin-5 receptor alpha chain antibody
Benralizumab
Elderly patient
Online Access:https://doi.org/10.1186/s12877-024-04683-1

Internet

https://doi.org/10.1186/s12877-024-04683-1

Similar Items